Blog
Patients
Erectile Dysfunction Sterile Injectable Medications
January 3, 2024
What Is Erectile Dysfunction? Erectile dysfunction (ED) is defined as difficulty achieving or maintaining an erection sufficient for sexual intercourse. […]
Alprostadil / Papaverine HCL / Phentolamine Mesylate (TriMix)
TriMix penile injection combines alprostadil, papaverine, and phentolamine which may offer a fast‑acting option that supports stronger and more reliable erections when oral medications are not achieving desired results.
Common dosage forms
Injectable
What is Alprostadil / Papaverine HCL / Phentolamine Mesylate?
Alprostadil, papaverine, and phentolamine (also known as TriMix injectable and TriMix injection) are combined for intracavernosal use, allowing the ingredients to act directly on penile tissue for rapid onset. This option may be chosen for individuals who do not achieve consistent results with oral PDE‑5 inhibitors (sildenafil citrate, vardenafil, and tadalafil) due to absorption differences, slower onset, or unwanted side effects.
Alprostadil injection functions as a prostaglandin vasodilator that may relax smooth muscle, papaverine increases cAMP and cGMP through non‑selective phosphodiesterase inhibition, and phentolamine may block alpha‑adrenergic receptors to reduce vasoconstriction. Together, these mechanisms may enhance blood flow and support firmer, more reliable erections.
TriMix may also allow lower individual ingredient strengths, which may help reduce side effects. Individuals at increased risk for priapism may require additional caution, while lifestyle factors such as exercise, diet, and smoking cessation may further support sexual wellness.
Benefits
What Are The Benefits Of Injectable Erectile Dysfunction Support?
While oral PDE-5 inhibitors (sildenafil citrate, vardenafil, and tadalafil) are considered first line therapy for erectile dysfunction, not all patients see success with these agents. Absorption variation, onset delays, and side effects may contribute to challenges individuals face when seeking appropriate erectile dysfunction therapy.
Compounded intracavernosal injections (ICI) are an alternative option for patients who have not succeeded or are ineligible for oral therapy.
When the moment strikes, waiting for medication to help isn’t always a reasonable request. Intracavernosal injections are thought to offer a more immediate onset of action for those unplanned intimate opportunities.
Who May Benefit From TriMix Therapy?
Individuals may benefit from TriMix therapy if they have erectile dysfunction and do not achieve dependable results with oral PDE‑5 inhibitors or experience issues such as poor absorption, slow onset, or unwanted side effects. Because the medication is injected directly into penile tissue, it may provide a faster and more reliable response during sexual activity.
It may also be helpful for those who cannot use oral ED medications due to medical conditions or interactions and prefer a multimodal approach that enhances blood flow through several pathways.
Access clinical studies on Alprostadil / Papaverine HCL / Phentolamine Mesylate (TriMix)
- Yafi FA, Jenkins L, Albersen M, Corona G, Isidori AM, Goldfarb S, Maggi M, Nelson CJ, Parish S, Salonia A, Tan R, Mulhall JP, Hellstrom WJ. Erectile dysfunction. Nat Rev Dis Primers. 2016 Feb 4;2:16003.
- Corona G, Rastrelli G, Morgentaler A, et al. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores. Eur Urol, 2017; 72(6):1000-1011.
- Hsiao W, Bennett N, Guhring P, Narus J, Mulhall JP. Satisfaction profiles in men using intracavernosal injection therapy. J Sex Med. 2011 Feb;8(2):512-7.
Access package insert for Alprostadil/Papaverine HCl/Phentolamine Mesylate Compound (TriMix)
Commonly Asked Questions
This drug trio is thought to provide a promising and well-tolerated erectile dysfunction intervention. Combining three therapeutic options allows multiple mechanisms of action to work simultaneously, with increased potential for sexual satisfaction.
This multimodal formulation may improve sexual outcomes with lower individual medication strengths, limiting the potential for side effects.
An intracavernosal injection (ICI) is a sterile medication administered directly into the penis, allowing the active ingredients to reach the target area immediately. By delivering the drug straight into the cavernosal tissue, ICI therapy may produce a faster and more reliable response compared to oral options.
Patients with conditions that raise the risk of priapism—such as sickle cell disease, leukemia, multiple myeloma, Peyronie’s disease, bleeding disorders, or a history of recurrent priapism—should consult a medical provider before using injectable erectile‑dysfunction medications. Those at higher risk may also need guidance on safety measures, including the possible use of rescue agents like injectable phenylephrine for emergency situations. Other health factors may influence candidacy as well, making a provider’s evaluation essential.
Alprostadil is a prostaglandin and vasodilator. It may relax the smooth muscle of the penis, dilating local arteries to increase blood flow and promote an erection.
Alprostadil may be a promising alternative for patients that do not succeed with oral phosphodiesterase type 5 inhibitors (PDE5i), like sildenafil citrate, tardenafil, or vardenafil.
Related Medications
Related Insights
Webinar
Clinicians
Erectile Dysfunction: An In-Depth Look at Hormone Therapies
December 8, 2023
Belmar Pharma Solutions’ FREE Educational Webinar Series proudly presents “Erectile Dysfunction: An In-Depth Look at Hormone Therapies” webinar hosted by […]
Get Started
Submit a Prescription
Become a Provider
